表紙:造影剤注入器の市場規模、シェア、成長分析、製品別、タイプ別、用途別、最終用途別、地域別 - 産業予測、2025年~2032年
市場調査レポート
商品コード
1755500

造影剤注入器の市場規模、シェア、成長分析、製品別、タイプ別、用途別、最終用途別、地域別 - 産業予測、2025年~2032年

Contrast Media Injectors Market Size, Share, and Growth Analysis, By Product (Injector Systems, Consumables), By Type (Single Head Injectors, Dual-Head Injectors), By Application, By End Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 188 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
造影剤注入器の市場規模、シェア、成長分析、製品別、タイプ別、用途別、最終用途別、地域別 - 産業予測、2025年~2032年
出版日: 2025年06月15日
発行: SkyQuest
ページ情報: 英文 188 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

造影剤注入器の世界市場規模は、2023年に19億米ドルと評価され、予測期間(2025-2032年)にCAGR 8.2%で成長し、2024年の20億6,000万米ドルから2032年には38億6,000万米ドルに成長する見通しです。

世界の造影剤注入器市場は、心血管疾患、がん、神経疾患などの慢性疾患の有病率の上昇によって大きく促進されています。これらの疾患にはCT、MRI、血管造影による正確な画像診断が必要であり、高度な造影剤注入器の需要が増加しています。このような病気にかかりやすい高齢化社会は、この需要をさらに促進し、画像診断処置の急増につながっています。その結果、ヘルスケア施設は画質を高め、造影剤の投与量を最適化する革新的な注入器に投資しています。さらに、低侵襲技術へのシフトは、効果的な診断と患者の安全性を促進する正確な造影剤供給システムの必要性を強調しています。自動注入器やデュアルヘッド注入器などの技術的進歩は、画像の精度とワークフローの効率を高め、市場の成長と精密診断の採用を促進しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

造影剤注入器市場規模:製品別& CAGR(2025-2032)

  • 市場概要
  • インジェクターシステム
    • CTインジェクターシステム
    • MRIインジェクターシステム
    • 心臓血管/血管造影インジェクターシステム
  • 消耗品
    • チューブ
    • 注射器
    • その他

造影剤注入器市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • シングルヘッドインジェクター
  • デュアルヘッドインジェクター
  • シリンジレスインジェクター

造影剤注入器市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 放射線科
  • インターベンショナルカーディオロジー
  • インターベンショナルラジオロジー

造影剤注入器市場規模:最終用途別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 診断センター
  • 外来手術センター

造影剤注入器市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • Bayer AG(Germany)
  • Medtronic plc(Ireland)
  • Bracco Imaging S.p.A.(Italy)
  • Guerbet(France)
  • Nemoto Kyorindo Co., Ltd.(Japan)
  • Ulrich GmbH & Co. KG(Germany)
  • APOLLO RT Co., Ltd.(Japan)
  • Shenzhen Anke High-tech Co., Ltd.(China)
  • SinoMD Technology Co., Ltd.(China)
  • Vivid Medical Imaging Products Co., Ltd.(China)
  • Mallinckrodt plc(Ireland)
  • GE Healthcare(USA)
  • Siemens Healthineers AG(Germany)
  • Philips(Netherlands)
  • Terumo Corporation(Japan)
  • Cook Medical(USA)
  • Acist Medical Systems, Inc.(USA)

結論と提言

目次
Product Code: SQMIG55A2056

Global Contrast Media Injectors Market size was valued at USD 1.9 billion in 2023 and is poised to grow from USD 2.06 billion in 2024 to USD 3.86 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The global contrast media injectors market is significantly propelled by the rising prevalence of chronic diseases, including cardiovascular diseases, cancer, and neurological disorders. These conditions necessitate accurate imaging diagnostics through CT, MRI, and angiography, increasing the demand for advanced contrast media injectors. The aging population, more vulnerable to such ailments, further fuels this demand, leading to a surge in diagnostic imaging procedures. Consequently, healthcare facilities are investing in innovative injectors that enhance image quality and optimize contrast media dosage. Additionally, the shift towards minimally invasive techniques underscores the need for precise contrast delivery systems that promote effective diagnosis and patient safety. Technological advancements, such as automated and dual-head injectors, are enhancing imaging accuracy and workflow efficiency, driving market growth and adoption of precision diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Media Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Media Injectors Market Segments Analysis

Global Contrast Media Injectors Market is segmented by Product, Type, Application, End Use and region. Based on Product, the market is segmented into Injector Systems, Consumables and Accessories. Based on Type, the market is segmented into Single Head Injectors, Dual-Head Injectors and Syringeless Injectors. Based on Application, the market is segmented into Radiology, Interventional Cardiology and Interventional Radiology. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contrast Media Injectors Market

The rising incidence of chronic illnesses, including cancer, cardiovascular diseases, and diabetes, is driving the demand for early diagnostic imaging. This heightened need for prompt diagnosis and patient monitoring encourages healthcare providers to utilize contrast media injectors more frequently. As a result, the market for these injectors is experiencing significant growth, reflecting a broader trend toward the adoption of advanced imaging technologies in healthcare settings. This shift not only facilitates better diagnosis and treatment but also underscores the importance of innovative solutions in improving patient outcomes in a landscape where timely medical intervention is crucial.

Restraints in the Global Contrast Media Injectors Market

The Global Contrast Media Injectors market faces significant challenges due to intricate regulatory frameworks governing medical devices. These regulatory processes often result in prolonged delays for product approvals and subsequently hinder timely market entry. Variations in regulations across different countries can further impede the momentum of innovation, restricting growth prospects and the integration of new technologies within the industry. Consequently, the regulatory landscape poses a substantial restraint, limiting both the advancement of novel contrast media injectors and the overall expansion of the market as a whole. Addressing these regulatory hurdles is crucial for fostering growth and innovation in this sector.

Market Trends of the Global Contrast Media Injectors Market

The Global Contrast Media Injectors market is witnessing a significant transformation driven by the integration of Artificial Intelligence (AI), which enhances precision, efficiency, and patient safety in diagnostic imaging. AI-powered systems utilize real-time analytics to tailor contrast dosing to individual patient characteristics, effectively reducing the incidence of contrast-induced nephropathy while improving image quality essential for accurate diagnoses. Automation capabilities in these injectors further minimize human errors and reduce contrast wastage, optimizing workflows within radiology departments. Prominent innovations, like Bayer's AI-integrated MEDRAD(R) Centargo CT Injection System, exemplify the trend toward enhanced operational efficiency, predictive analytics, and personalized imaging strategies, contributing to an expanding market landscape as healthcare increasingly embraces AI technologies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Contrast Media Injectors Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Injector Systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Tubing
    • Syringe
    • Others

Global Contrast Media Injectors Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Single Head Injectors
  • Dual-Head Injectors
  • Syringeless Injectors

Global Contrast Media Injectors Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

Global Contrast Media Injectors Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers

Global Contrast Media Injectors Market Size & CAGR (2025-2032)

  • North America (Product, Type, Application, End Use)
    • US
    • Canada
  • Europe (Product, Type, Application, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Type, Application, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Type, Application, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Type, Application, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bracco Imaging S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guerbet (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nemoto Kyorindo Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ulrich GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • APOLLO RT Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Anke High-tech Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SinoMD Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vivid Medical Imaging Products Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mallinckrodt plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acist Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations